Caliper gets OK for Zymark purchase

Caliper Technologies has been given the go-ahead by the US federal
Trade Commission for its $71 million cash and stock acquisition of
Zymark, a specialist in laboratory automation and robotics
equipment.

Caliper Technologies has been given the go-ahead by the US federal Trade Commission for its $71 million cash and stock acquisition of Zymark, a specialist in laboratory automation and robotics equipment. The companies expect the transaction to conclude by the end of this month.

When announcing the deal in June, Caliper chief executive James Knighton said that bringing Zymark on board would immediately add to earnings put the company on track to reach profitability in 2005.

The company is expecting the combination of its lab-on-a-chip technologies with Zymark's businesses to give it a lift into new areas such as new areas, such as analytical biochemistry, diagnostics, genetic analysis and genomics/proteomics.

Related news

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...

Follow us

Products

View more

Webinars